[IMCAS Asia 2026 Special ⑩ | Interview] "Clinical Outcomes Over Marketing and Trends" — Dr. Stephanie Young, JUVELOOK KOL
One of the most notable trends in aesthetic medicine today is the shift beyond volumizing fillers toward skin rejuvenation and biostimulation focused on improving skin quality itself. JUVELOOK, from VAIM, is a biostimulator combining PDLLA and HA: the HA provides immediate hydration and volume, while the PDLLA stimulates collagen synthesis over time. Designed for intradermal use, it is a skin booster aimed at improving overall skin quality, including texture and elasticity. In line with the current move toward natural-looking results rather than overfilling, it is drawing attention in Asia and beyond. At the VAIM booth during IMCAS Asia 2026 in Bangkok, Thailand, we spoke with Singapore-based oculoplastic surgeon Dr. Stephanie Young, one of the early users of JUVELOOK in Singapore and Southeast Asia. She shared the product's clinical strengths, her perspective on safety as a surgeon, her interest in combining it with energy-based devices, and her insights on the evolving standing of K-Medical Aesthetics — increasingly recognized on the strength of safety and clinical evidence — as well as the latest trends in Asian aesthetic medicine.
#MedicalAestheticNews #VAIM #JUVELOOK #IMCASAsia2026 #DrStephanieYoung
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20103

Comments
Post a Comment